Alicia Tee Fuay Ng

Title: Alicia Tee Fuay Ng: Innovator in Pharmaceutical Chemistry

Introduction

Alicia Tee Fuay Ng is a prominent inventor based in East Haven, CT (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline forms of various compounds. Her work has implications for the treatment of serious diseases, including cancer and HIV.

Latest Patents

Alicia holds 2 patents that focus on innovative pharmaceutical compositions. Her latest patents include crystalline forms of (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide. This patent provides a method of using these crystalline forms in the treatment of cancer and other proliferative diseases. Another patent discloses a crystalline form of N-[[4-fluoro-2-(5-methyl-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-C][1,4]-oxazine-2-carboxamide, sodium salt monohydrate, which is also aimed at treating AIDS or HIV infection.

Career Highlights

Alicia is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in pharmaceutical innovations. Her work is characterized by a commitment to improving therapeutic options for patients suffering from critical health conditions.

Collaborations

Alicia collaborates with esteemed colleagues, including Roxana Schlam and Chenkou Wei. These partnerships enhance the research environment and contribute to the successful development of new pharmaceutical solutions.

Conclusion

Alicia Tee Fuay Ng is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for innovative treatments. Her contributions are vital in the ongoing fight against serious diseases, showcasing the importance of research and collaboration in the field.